Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
1,775,633
-
Shares change
-
-159,292
-
Total reported value, excl. options
-
$46,871,606
-
Value change
-
-$4,662,042
-
Number of buys
-
21
-
Number of sells
-
-26
-
Price
-
$26.39
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q3 2022
74 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q3 2022.
ISHARES TR - GENOMICS IMMUN (IDNA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,775,633 shares
.
Largest 10 shareholders include Wharton Business Group, LLC (305,905 shares), MORGAN STANLEY (218,796 shares), Wealthcare Advisory Partners LLC (175,867 shares), UBS Group AG (146,216 shares), BANK OF AMERICA CORP /DE/ (125,116 shares), COMMONWEALTH EQUITY SERVICES, LLC (102,167 shares), LPL Financial LLC (77,355 shares), ROYAL BANK OF CANADA (62,350 shares), Kestra Advisory Services, LLC (52,469 shares), and AMERIPRISE FINANCIAL INC (38,336 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.